Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / January / What Will Redefine Pathology in 2026
Insights Genetics and epigenetics Software and hardware Technology and innovation Opinion and Personal Narratives Voices in the Community Digital Pathology

What Will Redefine Pathology in 2026?

Industry leaders outline how computational modeling and large-scale sequencing will reshape discovery, diagnostics, and clinical development in 2026 and beyond

By Jessica Allerton 01/14/2026 Future 5 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
  • Top Thought Leaders

Share

Top Institutions in Pathology and Genomic Medicine

Institutions were ranked based on their leadership in pathology, genomic medicine, AI in biomedical research, and large-scale population genomics initiatives, considering their history of pioneering research, clinical trials, and development of cutting-edge technologies in these fields.

  • #1

    Broad Institute of MIT and Harvard

    Cambridge, MA

    The Broad Institute is a global leader in genomic research and technology development, including long-read sequencing and population genomics, with extensive collaborations driving precision medicine and AI integration in biomedical research.

    Key Differentiators

    • Genomic Medicine
    • Pathology
    • Computational Biology
  • #2

    Johns Hopkins University School of Medicine

    Baltimore, MD

    Johns Hopkins has a strong history in neuropathology and genetic disease research, including Huntington’s disease and other repeat expansion disorders, with significant contributions to clinical and translational research integrating advanced sequencing technologies.

    Key Differentiators

    • Pathology
    • Neurology
    • Genetics
  • #3

    Stanford University School of Medicine

    Stanford, CA

    Stanford is recognized for its innovation in digital pathology, AI applications in research, and genomic medicine, actively developing AI platforms for hypothesis generation and experiment design in pathology and genetics.

    Key Differentiators

    • Pathology
    • Genomics
    • Biomedical Informatics
  • #4

    University of Washington School of Medicine

    Seattle, WA

    UW Medicine is a leader in population genomics and neurogenetics, contributing to large-scale pangenome projects and advancing technologies to resolve complex genetic repeats associated with neurodegenerative diseases.

    Key Differentiators

    • Genomic Medicine
    • Pathology
    • Neurogenetics
  • #5

    Mayo Clinic

    Rochester, MN

    Mayo Clinic integrates advanced genomic technologies with clinical pathology to improve diagnosis and treatment of genetic disorders, including repeat expansion diseases, and is expanding AI use in clinical research and laboratory medicine.

    Key Differentiators

    • Pathology
    • Genomic Medicine
    • Clinical Research

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Opening a Window into Brain Trauma
Insights
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Turning Tides
Insights
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

Molecular Spectacular
Insights
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Navigating Digital Scholarship and Professional Growth
Insights
Navigating Digital Scholarship and Professional Growth

January 16, 2024

5 min read

How can new-in-practice pathologists leverage the power of social media to enhance traditional academic work?

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.